Article
Generation of two isogenic control iPSC lines (LCSBi001-A-2 and LCSBi001-A-3) from a Parkinson's disease patient line (LCSBi001-A) carrying the pathogenic VPS35 p.D620N mutation.
Stem cell research - 1 Apr 2026
Boumpoureka Ioanna, Gorgogietas Vyron, Petkovski Elizabet, Massart François, Mellick George D, Krüger Rejko
Abstract excerpt
The pathogenic mutation VPS35 p.D620N has been identified to cause autosomal dominant, late-onset Parkinson's disease (PD) in multiple individuals and families worldwide. Here, we describe the generation of two new isogenic control lines (LCSBi001-A-2 and LCSBi001-A-3) from an already established patient-derived line (LCSBi001-A) carrying the heterozygous VPS35 p.D620N mutation. The control lines were generated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
